Bottom line
PILL vs TBXU: the short answer
PILL (Direxion Daily Pharmaceutical & Medical Bull 3X ETF) and TBXU (Direxion Daily Biotech Top 5 Bull 2X ETF) are both etfs.
But PILL is far broader, holding 73 positions to 10 for TBXU, so beyond the top names it adds exposure TBXU doesn't have.
Both charge the same expense ratio (0.98%).
Updated Nov 19, 2026
PILL vs TBXU side by side
| PILL | TBXU | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Direxion | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 0.98% | 0.98% |
| Annual cost per $10k | $98 | $98 |
| 10-yr cost on $10k (prospectus) | $1,456 | $5,645 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +75.0% | — |
| 5-yr return (annualized) | −12.6% | — |
| 10-yr return (annualized) | — | — |
| Best quarter | +103.7% | — |
| Worst quarter | −61.4% | — |
| Net assets (fund) | $20.7M | $2.6M |
| Number of holdings | 73 | 10 |
| Portfolio turnover | 88% | 69% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
5 of PILL's top 25 holdings also appear in TBXU's top 10.
| Holding | PILL | TBXU |
|---|---|---|
| Goldman Financial | 22.36% | 29.36% |
| N/a | 16.36% | 0.62% |
| Dreyfus | 8.14% | 21.64% |
| N/a | 7.41% | 0.62% |
| Goldman Sachs Liq Es Fd A | 2.03% | 6.23% |
Source: SEC Form N-PORT
PILL top 10
- Goldman Financial — 22.36%
- N/a — 16.36%
- Dreyfus — 8.14%
- N/a — 7.41%
- Crinetics Pharmaceuticals In — 2.77%
- Mbx Biosciences Inc — 2.42%
- Ataibeckley Inc — 2.16%
- Definium Therapeutics, Inc — 2.13%
- Goldman Sachs Liq Es Fd A — 2.03%
- Amylyx Pharmaceuticals Inc — 1.72%
TBXU top 10
- Goldman Financial — 29.36%
- Dreyfus — 21.64%
- Regeneron Pharmaceuticals Inc — 9.09%
- Amgen Inc — 7.95%
- Vertex Pharmaceuticals Inc — 7.84%
- Gilead Sciences Inc — 7.58%
- Argenx Se - Adr — 6.98%
- Goldman Sachs Liq Es Fd A — 6.23%
- N/a — 2.83%
- N/a — 0.62%
FAQ
What is the difference between PILL and TBXU?
PILL (Direxion Daily Pharmaceutical & Medical Bull 3X ETF) and TBXU (Direxion Daily Biotech Top 5 Bull 2X ETF) are both etfs. But PILL is far broader, holding 73 positions to 10 for TBXU, so beyond the top names it adds exposure TBXU doesn't have.
Which is cheaper, PILL or TBXU?
PILL has the lower expense ratio (0.98%).
Should I own both PILL and TBXU?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.